Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Dec;78(6):1648–1657. doi: 10.1172/JCI112758

Splanchnic insulin metabolism in obesity. Influence of body fat distribution.

A N Peiris, R A Mueller, G A Smith, M F Struve, A H Kissebah
PMCID: PMC423938  PMID: 3537010

Abstract

The effects of obesity and body fat distribution on splanchnic insulin metabolism and the relationship to peripheral insulin sensitivity were assessed in 6 nonobese and 16 obese premenopausal women. When compared with the nonobese women, obese women had significantly greater prehepatic production and portal vein levels of insulin both basally and following glucose stimulation. This increase correlated with the degree of adiposity but not with waist-to-hip girth ratio (WHR). WHR, however, correlated inversely with the hepatic extraction fraction and directly with the posthepatic delivery of insulin. The latter correlated with the degree of peripheral insulinemia. The decline in hepatic insulin extraction with increasing WHR also correlated with the accompanying diminution in peripheral insulin sensitivity. Increasing adiposity is thus associated with insulin hypersecretion. The pronounced hyperinsulinemia of upper body fat localization, however, is due to an additional defect in hepatic insulin extraction. This defect is closely allied with the decline in peripheral insulin sensitivity.

Full text

PDF
1648

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar R. S., Harrison L. C., Muggeo M., Gorden P., Kahn C. R., Roth J. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med. 1979;24:23–52. [PubMed] [Google Scholar]
  2. Berger W., Göschke H., Moppert J., Künzli H. Insulin concentrations in portal venous and peripheral venous blood in man following administration of glucose, galactose, xylitol and tobutamide. Horm Metab Res. 1973 Jan;5(1):4–8. doi: 10.1055/s-0028-1093991. [DOI] [PubMed] [Google Scholar]
  3. Bogardus C., Lillioja S., Mott D. M., Hollenbeck C., Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol. 1985 Mar;248(3 Pt 1):E286–E291. doi: 10.1152/ajpendo.1985.248.3.E286. [DOI] [PubMed] [Google Scholar]
  4. Bonora E., Zavaroni I., Bruschi F., Alpi O., Pezzarossa A., Guerra L., Dall'Aglio E., Coscelli C., Butturini U. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab. 1984 Dec;59(6):1121–1127. doi: 10.1210/jcem-59-6-1121. [DOI] [PubMed] [Google Scholar]
  5. Bratusch-Marrain P. R., Waldhäusl W. K., Gasić S., Hofer A. Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans. Metabolism. 1984 Feb;33(2):151–157. doi: 10.1016/0026-0495(84)90128-8. [DOI] [PubMed] [Google Scholar]
  6. Burghen G. A., Kitabchi A. E., Brush J. S. Characterization of a rat liver protease with specificity for insulin. Endocrinology. 1972 Sep;91(3):633–642. doi: 10.1210/endo-91-3-633. [DOI] [PubMed] [Google Scholar]
  7. CAESAR J., SHALDON S., CHIANDUSSI L., GUEVARA L., SHERLOCK S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961 Aug;21:43–57. [PubMed] [Google Scholar]
  8. Chideckel E. W., Palmer J., Koerker D. J., Ensinck J., Davidson M. B., Goodner C. J. Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis. J Clin Invest. 1975 Apr;55(4):754–762. doi: 10.1172/JCI107986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Curry D. L., Stern J. S. Dynamics of insulin hypersecretion by obese Zucker rats. Metabolism. 1985 Sep;34(9):791–796. doi: 10.1016/0026-0495(85)90100-3. [DOI] [PubMed] [Google Scholar]
  10. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  11. Durnin J. V., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974 Jul;32(1):77–97. doi: 10.1079/bjn19740060. [DOI] [PubMed] [Google Scholar]
  12. Eaton R. P., Allen R. C., Schade D. S., Erickson K. M., Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab. 1980 Sep;51(3):520–528. doi: 10.1210/jcem-51-3-520. [DOI] [PubMed] [Google Scholar]
  13. Eaton R. P., Friedman N., Allen R. C., Schade D. S. Insulin removal in man: in vivo evidence for a receptor-mediated process. J Clin Endocrinol Metab. 1984 Mar;58(3):555–559. doi: 10.1210/jcem-58-3-555. [DOI] [PubMed] [Google Scholar]
  14. Evans D. J., Hoffmann R. G., Kalkhoff R. K., Kissebah A. H. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1983 Aug;57(2):304–310. doi: 10.1210/jcem-57-2-304. [DOI] [PubMed] [Google Scholar]
  15. Evans D. J., Hoffmann R. G., Kalkhoff R. K., Kissebah A. H. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism. 1984 Jan;33(1):68–75. doi: 10.1016/0026-0495(84)90164-1. [DOI] [PubMed] [Google Scholar]
  16. Evans D. J., Murray R., Kissebah A. H. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J Clin Invest. 1984 Oct;74(4):1515–1525. doi: 10.1172/JCI111565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Faber O. K., Christensen K., Kehlet H., Madsbad S., Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab. 1981 Sep;53(3):618–621. doi: 10.1210/jcem-53-3-618. [DOI] [PubMed] [Google Scholar]
  18. Faber O. K., Hagen C., Binder C., Markussen J., Naithani V. K., Blix P. M., Kuzuya H., Horwitz D. L., Rubenstein A. H., Rossing N. Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest. 1978 Jul;62(1):197–203. doi: 10.1172/JCI109106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ferrannini E., Wahren J., Faber O. K., Felig P., Binder C., DeFronzo R. A. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol. 1983 Jun;244(6):E517–E527. doi: 10.1152/ajpendo.1983.244.6.E517. [DOI] [PubMed] [Google Scholar]
  20. Field J. B. Extraction of insulin by liver. Annu Rev Med. 1973;24:309–314. doi: 10.1146/annurev.me.24.020173.001521. [DOI] [PubMed] [Google Scholar]
  21. Horwitz D. L., Starr J. I., Mako M. E., Blackard W. G., Rubenstein A. H. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 1975 Jun;55(6):1278–1283. doi: 10.1172/JCI108047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jeanrenaud B. Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology. Metabolism. 1978 Dec;27(12 Suppl 2):1881–1892. doi: 10.1016/s0026-0495(78)80006-7. [DOI] [PubMed] [Google Scholar]
  23. Kissebah A. H., Vydelingum N., Murray R., Evans D. J., Hartz A. J., Kalkhoff R. K., Adams P. W. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982 Feb;54(2):254–260. doi: 10.1210/jcem-54-2-254. [DOI] [PubMed] [Google Scholar]
  24. Mahler R. J., Szabo O. Amelioration of insulin resistance in obese mice. Am J Physiol. 1971 Oct;221(4):980–983. doi: 10.1152/ajplegacy.1971.221.4.980. [DOI] [PubMed] [Google Scholar]
  25. Mahler R. J. The pathogenesis of pancreatic islet cell hyperplasia and insulin insensitivity in obesity. Adv Metab Disord. 1974;7(0):213–241. doi: 10.1016/b978-0-12-027307-2.50016-5. [DOI] [PubMed] [Google Scholar]
  26. McGuire E. A., Tobin J. D., Berman M., Andres R. Kinetics of native insulin in diabetic, obese, and aged men. Diabetes. 1979 Feb;28(2):110–120. doi: 10.2337/diab.28.2.110. [DOI] [PubMed] [Google Scholar]
  27. Meistas M. T., Rendell M., Margolis S., Kowarski A. A. Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide. Study in obese and diabetic subjects. Diabetes. 1982 May;31(5 Pt 1):449–453. doi: 10.2337/diab.31.5.449. [DOI] [PubMed] [Google Scholar]
  28. Misbin R. I., Merimee T. J., Lowenstein J. M. Insulin removal by isolated perfused rat liver. Am J Physiol. 1976 Jan;230(1):171–177. doi: 10.1152/ajplegacy.1976.230.1.171. [DOI] [PubMed] [Google Scholar]
  29. Mondon C. E., Olefsky J. M., Dolkas C. B., Reaven G. M. Removal of insulin by perfused rat liver: effect of concentration. Metabolism. 1975 Feb;24(2):153–160. doi: 10.1016/0026-0495(75)90016-5. [DOI] [PubMed] [Google Scholar]
  30. Morgan C. R., Spahn J., Frazier V., Fleitz S. Insulin a possible inducer of the biosynthesis of rat liver insulinase. Proc Soc Exp Biol Med. 1968 Jul;128(3):795–797. doi: 10.3181/00379727-128-33125. [DOI] [PubMed] [Google Scholar]
  31. Polonsky K. S., Licinio-Paixao J., Given B. D., Pugh W., Rue P., Galloway J., Karrison T., Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest. 1986 Jan;77(1):98–105. doi: 10.1172/JCI112308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Polonsky K. S., Pugh W., Jaspan J. B., Cohen D. M., Karrison T., Tager H. S., Rubenstein A. H. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J Clin Invest. 1984 Nov;74(5):1821–1829. doi: 10.1172/JCI111601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Polonsky K. S., Rubenstein A. H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes. 1984 May;33(5):486–494. doi: 10.2337/diab.33.5.486. [DOI] [PubMed] [Google Scholar]
  34. Polonsky K., Jaspan J., Pugh W., Cohen D., Schneider M., Schwartz T., Moossa A. R., Tager H., Rubenstein A. H. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest. 1983 Sep;72(3):1114–1123. doi: 10.1172/JCI111036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Raison J., Achimastos A., Bouthier J., London G., Safar M. Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. Am J Cardiol. 1983 Jan 1;51(1):165–170. doi: 10.1016/s0002-9149(83)80030-7. [DOI] [PubMed] [Google Scholar]
  36. Rossell R., Gomis R., Casamitjana R., Segura R., Vilardell E., Rivera F. Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab. 1983 Mar;56(3):608–611. doi: 10.1210/jcem-56-3-608. [DOI] [PubMed] [Google Scholar]
  37. Savage P. J., Flock E. V., Mako M. E., Blix P. M., Rubenstein A. H., Bennett P. H. C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. J Clin Endocrinol Metab. 1979 Apr;48(4):594–598. doi: 10.1210/jcem-48-4-594. [DOI] [PubMed] [Google Scholar]
  38. Soli A. H., Kahn C. R., Neville D. M., Jr, Roth J. Insulin receptor deficiency in genetic and acquired obesity. J Clin Invest. 1975 Oct;56(4):769–780. doi: 10.1172/JCI108155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Stoll R. W., Touber J. L., Menahan L. A., Williams R. H. Clearance of porcine insulin, proinsulin, and connecting peptide by the isolated rat liver. Proc Soc Exp Biol Med. 1970 Mar;133(3):894–896. doi: 10.3181/00379727-133-34589. [DOI] [PubMed] [Google Scholar]
  40. Terris S., Steiner D. F. Retention and degradation of 125I-insulin by perfused livers from diabetic rats. J Clin Invest. 1976 Apr;57(4):885–896. doi: 10.1172/JCI108365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Waldhäusl W., Bratusch-Marrain P., Gasic S., Korn A., Nowotny P. Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia. 1979 Oct;17(4):221–227. doi: 10.1007/BF01235858. [DOI] [PubMed] [Google Scholar]
  42. Walter R. M., Gold E. M., Michas C. A. Portal and peripheral vein concentrations of insulin after glucose and arginine infusions in morbidly obese subjects. Life Sci. 1980 Jan 28;26(4):261–266. doi: 10.1016/0024-3205(80)90335-5. [DOI] [PubMed] [Google Scholar]
  43. Walter R. M., Jr, Gold E. M., Michas C. A., Ensinck J. W. Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects. Metabolism. 1980 Oct;29(11):1037–1040. doi: 10.1016/0026-0495(80)90213-9. [DOI] [PubMed] [Google Scholar]
  44. White J. J., Dupré J. Regulation of insulin secretion by the intestinal hormone, secretin: studies in man via transumbilical portal vein catheterization. Surgery. 1968 Jul;64(1):204–213. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES